H. Wallick

2.1k total citations · 2 hit papers
16 papers, 1.6k citations indexed

About

H. Wallick is a scholar working on Pharmacology, Molecular Biology and Molecular Medicine. According to data from OpenAlex, H. Wallick has authored 16 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 5 papers in Molecular Biology and 4 papers in Molecular Medicine. Recurrent topics in H. Wallick's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Microbial Natural Products and Biosynthesis (4 papers) and Antibiotic Resistance in Bacteria (4 papers). H. Wallick is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Microbial Natural Products and Biosynthesis (4 papers) and Antibiotic Resistance in Bacteria (4 papers). H. Wallick collaborates with scholars based in United States, Belgium and Japan. H. Wallick's co-authors include E. O. Stapley, David Hendlin, Jerome Birnbaum, H. B. Woodruff, A. Kathrine Miller, Satoshi Ōmura, Irving Putter, Robert Hartman, Richard W. Burg and Brinton M. Miller and has published in prestigious journals such as Science, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

H. Wallick

16 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Avermectins, New Family of Potent Anthelmintic Agents: Producing Organism and Fermentation

1979 728 citations Richard W. Burg, Brinton M. Miller et al. Antimicrobial Agents and Chemotherapy profile →
Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces

1969 473 citations David Hendlin, E. O. Stapley et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Wallick United States	11	611	553	315	267	251	16	1.6k
Jerome Birnbaum United States	17	839 1.4×	1.0k 1.9×	569 1.8×	354 1.3×	291 1.2×	35	2.4k
Sara Currie United States	7	542 0.9×	671 1.2×	232 0.7×	300 1.1×	275 1.1×	10	1.4k
Herbert A. Kirst United States	27	972 1.6×	561 1.0×	178 0.6×	702 2.6×	401 1.6×	72	2.3k
RUIKO OIWA Japan	19	733 1.2×	691 1.2×	47 0.1×	432 1.6×	337 1.3×	38	1.7k
J. Allan Waitz United States	21	449 0.7×	632 1.1×	428 1.4×	174 0.7×	86 0.3×	56	1.4k
Manuel Debono United States	20	783 1.3×	602 1.1×	56 0.2×	418 1.6×	163 0.6×	44	1.7k
Shōgo Kuwahara Japan	22	429 0.7×	643 1.2×	346 1.1×	173 0.6×	111 0.4×	82	1.7k
Christopher Reading United States	13	640 1.0×	875 1.6×	582 1.8×	286 1.1×	116 0.5×	21	1.6k
S. Mochales United States	9	486 0.8×	563 1.0×	378 1.2×	351 1.3×	181 0.7×	10	1.3k
Katsukiyo Yazawa Japan	32	810 1.3×	686 1.2×	115 0.4×	398 1.5×	357 1.4×	118	2.4k

Countries citing papers authored by H. Wallick

Since Specialization

Citations

This map shows the geographic impact of H. Wallick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Wallick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Wallick more than expected).

Fields of papers citing papers by H. Wallick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Wallick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Wallick. The network helps show where H. Wallick may publish in the future.

Co-authorship network of co-authors of H. Wallick

This figure shows the co-authorship network connecting the top 25 collaborators of H. Wallick. A scholar is included among the top collaborators of H. Wallick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Wallick. H. Wallick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wallick, H., et al.. (2002). Discovery and antimicrobial properties of cathomycin, a new antibiotic produced by Streptomyces spheroides n. sp.. PubMed. 3. 909–17. 8 indexed citations

Stapley, E. O., Jerome Birnbaum, A. Kathrine Miller, et al.. (1979). Cefoxitin and Cephamycins: Microbiological Studies. Clinical Infectious Diseases. 1(1). 73–87. 36 indexed citations

Birnbaum, Jerome, E. O. Stapley, A. Kathrine Miller, et al.. (1979). Development of the semisynthetic cephamycin, cefoxitin, as a clinical candidate. Infection. 7(S1). S13–S20. 4 indexed citations

Burg, Richard W., Brinton M. Miller, Edward Baker, et al.. (1979). Avermectins, New Family of Potent Anthelmintic Agents: Producing Organism and Fermentation. Antimicrobial Agents and Chemotherapy. 15(3). 361–367. 728 indexed citations breakdown →

Birnbaum, Jerome, E. O. Stapley, A. Kathrine Miller, et al.. (1978). Cefoxitin, a semi-synthetic cephamycin: a microbiological overview. Journal of Antimicrobial Chemotherapy. 4(suppl B). 15–32. 32 indexed citations

Woodruff, H. B., J.M. Mata, Sebastían Hernández, et al.. (1977). Fosfomycin: Laboratory Studies. Chemotherapy. 23(1). 1–22. 47 indexed citations

Wallick, H. & David Hendlin. (1974). Cefoxitin, a Semisynthetic Cephamycin Antibiotic: Susceptibility Studies. Antimicrobial Agents and Chemotherapy. 5(1). 25–32. 86 indexed citations

Loo, J.C.K., Elwood L. Foltz, H. Wallick, & K.C. Kwan. (1974). Pharmacokinetics of pivampicillin and ampicillin in man. Clinical Pharmacology & Therapeutics. 16(1part1). 35–43. 34 indexed citations

Ōnishi, Hiroshi, et al.. (1973). Cephamycins, a New Family of β-Lactam Antibiotics: Antibacterial Activity and Resistance to β-Lactamase Degradation. Antimicrobial Agents and Chemotherapy. 3(2). 254–261. 51 indexed citations

10.

Wallick, H., et al.. (1970). Clinical pharmacology of pivampicillin.. PubMed. 10. 442–54. 38 indexed citations

11.

Hendlin, David, E. O. Stapley, M. Jackson, et al.. (1969). Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces. Science. 166(3901). 122–123. 473 indexed citations breakdown →

12.

Wallick, H., et al.. (1969). Pharmacodynamics of phosphonomycin after oral administration in man.. PubMed. 9. 322–6. 7 indexed citations

13.

Wallick, H., et al.. (1969). Pharmacodynamics of phosphonomycin after intravenous administration in man.. PubMed. 9. 316–21. 5 indexed citations

14.

Hendlin, David, et al.. (1968). Antibiotic MSD-819. I. Microbial production and biological characteristics.. PubMed. 8. 249–54. 2 indexed citations

15.

Page, A. C., Paul H. Gale, H. Wallick, et al.. (1960). Coenzyme Q. XVII. Isolation of coenzyme Q10 from bacterial fermentation. Archives of Biochemistry and Biophysics. 89(2). 318–321. 58 indexed citations

16.

Wallick, H., et al.. (1955). Discovery, development, and antimicrobial properties of D-4-amino-3-isoxazolidone (oxamycin), a new antibiotic produced by Streptomyces garyphalus n. sp.. PubMed. 5(4). 183–90. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact